Facebook Twitter LinkedIn Google Plus RSS

MorphoSys rises on $818M drug alliance: Frankfurt Mover Source: Bloomberg News

MorphoSys AG rose to a 12-year high after announcing an alliance for an experimental cancer treatment with Celgene Corp. worth as much as 628 million euros ($818 million) plus royalties on sales.

Continue Reading »»

Also Popular on NJBIZ

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy